Accès gratuit
Med Sci (Paris)
Volume 25, Numéro 3, Mars 2009
Page(s) 307 - 310
Section Forum
Publié en ligne 15 mars 2009
  1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216 : 136–44. [Google Scholar]
  2. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264 : 566–9. [Google Scholar]
  3. Coustou V, Deleu C, Saupe S, Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 1997; 94 : 9773–8. [Google Scholar]
  4. Tuite MF, Cox BS. Propagation of yeast prions. Nat Rev Mol Cell Biol 2003; 4 : 878–90. [Google Scholar]
  5. Ferreira PC, Ness F, Edwards SR, et al. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 2001; 40 : 1357–69. [Google Scholar]
  6. Zenthon JF, Ness F, Cox B, Tuite MF. The [PSI+] prion of Saccharomyces cerevisiae can be propagated by an Hsp104 orthologue from Candida albicans. Eukaryot Cell 2006; 5 : 217–25. [Google Scholar]
  7. Kryndushkin DS, Smirnov VN, Ter-Avanesyan MD, Kushnirov VV. Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J Biol Chem 2002; 277 : 23702–8. [Google Scholar]
  8. Tribouillard D, Bach S, Gug F, et al. Using budding yeast to screen for anti-prion drugs. Biotechnol J 2006; 1 : 58–67. [Google Scholar]
  9. Bach S, Talarek N, Andrieu T, et al. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol 2003; 21 : 1075–81. [Google Scholar]
  10. Tribouillard-Tanvier D, Beringue V.Antihypertensive drug Guanabenz is active in vivo against both yeast and mammalian prion. PLoS ONE 2008; 3 : e1981 [Google Scholar]
  11. Kajava AV, Baxa U, Wickner RB, Steven AC. A model for Ure2p prion filaments and other amyloids: the parallel superpleated beta-structure. Proc Natl Acad Sci USA 2004; 101 : 7885–90. [Google Scholar]
  12. Kajava AV, Aebi U, Steven AC. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J Mol Biol 2005; 348 : 247–252. [Google Scholar]
  13. Petkova AT, Ishii Y, Balbach JJ, et al. A structural model for Alzheimer’s beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002; 99 : 16742–7. [Google Scholar]
  14. Ritter C, Maddelein ML, Siemer AB, et al. Correlation of structural elements and infectivity of the HET-s prion. Nature. 2005; 435 : 844–8. [Google Scholar]
  15. Govaerts C, Wille H, Prusiner SB, Cohen FE. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci USA 2004; 101 : 8342–7. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.